Primech Holdings 株価情報 (NASDAQ: PMEC)

最新ニュース Primech Holdings (NASDAQ:PMEC) 株価情報

Primech Holdings

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Movers

Trading Ideas

BIMI

DALN

FFIE

FGEN

GRPN

JTAI

LMND

MGNX

NUZE

PITA

PMEC

POWL

TBIO

TIVC

アドバンスト マイクロ デバイセズ社 (NASDAQ:AMD) の株は、予想を上回る第2四半期決算を受けて本日のプレマーケット取引で急騰している。

AMD株価上昇　決算を受けて

Primech Holdings Ltd

Box, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) reported its third-quarter results after Tuesday's closing bell. Here's a look at the details <a href="https://www.benzinga.com/pressreleases/24/12/b42301797/box-reports-fiscal-third-quarter-2025-financial-results">from the report. </a>
The Details: Box reported quarterly earnings of 45 cents per share, which beat the analyst consensus estimate of 42 cents. Quarterly revenue came in at $276 million, which beat the consensus estimate of $275.17 million and is an increase over sales of $261.54 million from the same period last year.
<ul>
<li>Remaining performance obligations (RPO) as of Oct. 31, 2024, were $1.282 billion, a 13% increase year-over-year.</li>
<li>Billings for the third quarter of fiscal 2025 were $264.7 million, a 4% increase from billings for the third quarter of fiscal 2024 of $253.7 million. </li>
<li>Third-quarter billings were impacted by a roughly 100 basis point tailwind from FX versus the company&#8217;s prior expectations of 210 basis point tailwind.</li>
<li>Non-GAAP gross profit for the third quarter of fiscal 2025 was a record $226.1 million, or 81.9% of revenue. </li>
<li>Non-GAAP operating income in the third quarter of fiscal 2025 was a record $80.2 million, or 29.1% of revenue. </li>
</ul>
Read Next: <a href="https://www.benzinga.com/24/12/42298242/tiktok-shop-bags-more-than-100-million-in-black-friday-sales">TikTok Shop Bags More Than $100 Million In Black Friday Sales With Potential Ban Ahead</a>
&#8220;We delivered strong third-quarter financial results and unveiled the most transformational product line-up in Box history,&#8221; said Aaron Levie, CEO of Box. &#8220;Now businesses of all sizes will be able to realize the full value of their content and leverage the data inside their files to drive innovation, automate processes, and secure their most important information as we drive a new era of Intelligent Content Management.&#8221;
Outlook:&nbsp;Box sees fourth-quarter revenue of $279 million, versus the $278.544 million estimate, and adjusted earnings of 41 cents per share, in line with estimates.
BOX Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Box shares are down 4.13% after-hours at $33 at the time of publication Tuesday. 
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42300548/art-cashins-lessons-cuban-crisis-trades-to-timeless-wall-street-wit">Art Cashin&#8217;s Lessons: Cuban Crisis Trades To Timeless Wall Street Wit</a></li>
</ul>
Photo: Courtesy of Box, Inc.

Earnings

News

Guidance

After-Hours Center

Box Stock Dips After Narrow Q3 EPS, Revenue Beats: Details

Iron Mountain Prices Upsized Offering By Way Of Private Placement Of $1.2B Of Its 6.25% Senior Notes Due 2033

Management

Stewart Information Services Agrees With CEO Frederick Eppinger To Amend And Restate His Employment Agreement, Extending Term For Another Three Years Through End Of 2028

Buybacks

RUSHA

Rush Enterprises Board Approves New Stock Repurchase Program Of Up To An Aggregate Of $150M Of Its Shares Of Class A Common Stock

The price of the<a href="https://www.benzinga.com/money/ripple-xrp-price-prediction"> XRP Token</a> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) from Ripple continues to climb thanks to optimism about the incoming White House administration and potential XRP ETFs, leading to the cryptocurrency recently flipping Tether and Solana to become the<a href="https://www.benzinga.com/24/12/42259460/xrp-beats-solana-to-become-4th-largest-crypto-by-market-cap-on-ripples-rlusd-approval-speculation"> third-largest crypto.</a>
What Happened: The price of XRP is up 87% over <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42296482/xrp-price-explodes-415-in-30-days-experts-analyze-why-xrp-is-going-up">the last seven days,</a> hitting new one-month and one-year highs.
The price action could be pinpointed to the anticipation of new leadership at the SEC, a financial institution that has often clashed with Ripple. A new change could see XRP and other cryptos face less or no government resistance moving forward, minimizing risk for investors.
Cryptocurrency experts also told Benzinga that Ripple's partnerships with financial institutions could be the reason for the increase in cryptocurrency&#8217;s price. The filing of several XRP ETFs also has investors excited about a potential larger spotlight on the cryptocurrency and more ways for investors to gain exposure.
While XRP has hit new one-year highs of $2.86 in the last 24 hours and the cryptocurrency is up over 280% year-to-date, the price still trails an all-time high of $3.84 set back in January 2018.
Also happening in 2018 was a Ripple community event at the three-day Consensus conference that saw Snoop Dogg booked as the entertainer and performer for the Ripple community.
Snoop Dogg, who has supported the cryptocurrency sector and non-fungible tokens, performed at a private invitation-only Consensus after-party from Ripple Labs on May 15, 2018.
The performance in New York saw several media outlets <a href="https://www.coindesk.com/markets/2018/05/19/at-ripples-snoop-dogg-party-a-search-for-xrp">cover </a>Snoop Dogg's appearance and the fact that he did not talk about investing in cryptocurrency during his performance. Instead, the event was much like a celebration for the XRP community. Ripple previously said they did not pay Snoop Dogg with XRP tokens for his appearance.
While celebrities endorsing cryptocurrencies is nothing new, Snoop Dogg's appearance may have marked an opportune moment to consider buying XRP—though the rapper offered no direct investment advice during the event.
Read Also: <a href="https://www.benzinga.com/24/11/42225289/heres-how-much-100-invested-in-xrp-token-today-will-be-worth-if-crypto-returns-to-all-time-highs">Here&#8217;s How Much $100 Invested In XRP Token Today Will Be Worth If Crypto Returns To All-Time Highs</a>
Investing $1,000 in XRP: Investors who learned about XRP for the first time with news of his appearance at the Ripple event, or thought that his appearance could signal optimism for the XRP token going forward may have considered buying the cryptocurrency.
A $1,000 investment at the high price of $0.7523 on May 15, 2018 could have bought 1,329.26 XRP. The $1,000 investment would be worth $3,429.49 today based on a price of $2.58 at the time of writing, up 242.9%.
XRP continues to be one of the most talked about cryptocurrency in recent months, and its continued strength and the potential approval of ETFs could lead to a higher price for the coin.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/11/42173824/if-you-invested-1000-in-xrp-token-when-sec-lawsuit-caused-mass-panic-heres-how-much-youd-have-today">If You Invested $1,000 In XRP Token When SEC Lawsuit Caused Mass Panic, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
Image created using a photo from Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$XRP

If You Invested $1,000 In XRP Token When Snoop Dogg Performed At Ripple Community Event At Consensus 2018, Here's How Much You'd Have Today

He will continue to lead the company during the executive search process for his successor.

GXO Logistics Says CEO Malcolm Wilson Has Informed Board That He Plans To Retire In 2025

Pure Storage, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) shares are soaring after the company reported its third-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/12/n42301813/pure-storage-announces-third-quarter-fiscal-2025-financial-results">details from the report. </a>
The Details: Pure Storage reported quarterly earnings of 50 cents per share, which beat the analyst consensus estimate of 42 cents. Quarterly revenue came in at $831.07 million which beat the consensus estimate of $818.14 million and is an increase over sales of $762.84 million from the same period last year.
Pure Storage reported: 
<ul>
<li>Subscription services revenue of $376.4 million, up 22% year-over-year. </li>
<li>Subscription annual recurring revenue (ARR) of $1.6 billion, up 22% year-over-year. </li>
<li>Remaining performance obligations (RPO) of $2.4 billion, up 16% year-over-year.</li>
<li>Non-GAAP gross margin was 71.9%. </li>
<li>Non-GAAP operating income was $167.3 million. </li>
<li>Non-GAAP operating margin was 20.1%.</li>
<li>Operating cash flow of $97 million. </li>
<li>Free cash flow of $35.2 million</li>
</ul>
&#8220;Pure Storage has achieved another industry first in our journey of data storage innovation with a transformational design win for our DirectFlash technology in a top-four hyperscaler,&#8221; said Pure Storage CEO Charles Giancarlo. 
&#8220;This win is the vanguard for Pure Flash technology to become the standard for all hyperscaler online storage, providing unparalleled performance and scalability while also reducing operating costs and power consumption,&#8221; Giancarlo added. 
Read Next: <a href="https://www.benzinga.com/24/12/42298242/tiktok-shop-bags-more-than-100-million-in-black-friday-sales">TikTok Shop Bags More Than $100 Million In Black Friday Sales With Potential Ban Ahead</a>
Outlook:&nbsp;Pure Storage sees fourth-quarter revenue of $867 million, versus the $856.93 million estimate, and fiscal 2025 revenue of $3.15 billion, versus the $3.13 billion estimate. 
PSTG Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Pure Storage shares are up 23.55% after-hours at $66.15 at the time of publication Tuesday. 
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42300548/art-cashins-lessons-cuban-crisis-trades-to-timeless-wall-street-wit">Art Cashin&#8217;s Lessons: Cuban Crisis Trades To Timeless Wall Street Wit</a></li>
</ul>
Photo: Courtesy of Pure Storage, Inc.

Tech

PSTG

Pure Storage Shares Soar After Strong Q3, Q4 Guidance Above Estimates: Details

ATIP

NYSE To Begin Delisting Proceedings Against ATI Physical Therapy

Macro Economic Events

Commodities

Econ #s

Economics

Markets

USA API Weekly Crude Oil Stock 1.232M Barrel Build vs 2.060M Barrel Draw Est.; Draw Of 5.935M Barrels Prior

TCB is a St Louis, Missouri-based, privately held intermodal marketing company specializing in the movement of 40 and 53-foot containers across North America. The Company acquired TCB through its wholly-owned subsidiary Radiant Road and Rail, Inc. and structured the transaction similar to its previous transactions, with a portion of the expected purchase price payable in subsequent periods based on the future performance of the acquired operations.

RLGT

Radiant Logistics Acquires Assets And Operations Of TCB Transportation Associates, LLC For Undisclosed Terms; Strengthens Brokerage Platform With Enhanced Intermodal Capabilities

Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) reported third-quarter financial results after the market close on Tuesday. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/12/b42301576/okta-announces-third-quarter-fiscal-year-2025-financial-results">rundown of the report</a>.
Q3 Earnings: Okta reported third-quarter revenue of $665 million, beating analyst <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $649.7 million. The cloud-native cybersecurity company reported adjusted earnings of 67 cents per share, beating analyst estimates of 58 cents per share, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue and subscription revenue were both up 14% on a year-over-year basis. Remaining performance obligations totaled $3.66 billion at quarter&#8217;s end, up 19% year-over-year.
Net cash provided by operations was&nbsp;$159 million, up from $154 million in the prior year's quarter. The company generated free cash flow of $154 million in the quarter, up from $150 million year-over-year. Okta ended the quarter with $2.25 billion in cash, cash equivalents and short-term investments.
&#8220;Our solid third-quarter results were underpinned by continued strong profitability and cash flow. The focused investments we&#8217;ve made in our partner ecosystem, the public sector vertical, and large customers are materializing in our business with each of these areas contributing meaningfully to top-line growth,&#8221; said Todd McKinnon, co-founder and CEO of Okta.
&#8220;Okta&#8217;s commitment to innovation and elevating identity security is resonating with customers of all sizes as they look to Okta to modernize their identity infrastructure.&#8221;
What&#8217;s Next: Okta sees fourth-quarter revenue in the range of $667 million to $669 million versus estimates of $650.64 million. The company anticipates fourth-quarter adjusted earnings&nbsp;of 73 to 74 cents per share versus estimates of 67 cents per share.&nbsp;
Okta expects full-year revenue to be in the range of $2.595 billion to $2.597 billion versus estimates of $2.563 billion. The company expects full-year adjusted earnings to be between $2.75 and $2.76 per share versus estimates of $2.61 per share.
Management will hold a conference call with analysts and investors at 5 p.m. ET to further discuss the company&#8217;s quarterly performance.
OKTA Price Action: <a href="https://www.benzinga.com/quote/OKTA" target="_blank" rel="noreferrer noopener">Okta shares</a> were up 19.31% in after-hours, trading at $97.49 at the time of publication, per <a href="http://pro.benzinga.com" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42298242/tiktok-shop-bags-more-than-100-million-in-black-friday-sales">TikTok Shop Bags More Than $100 Million In Black Friday Sales With Potential Ban Ahead</a></li>
</ul>
Photo: Shutterstock.

OKTA

Okta Q3 Earnings: Revenue Beat, EPS Beat, Strong Guidance, Shares Surge

The district court decision concludes the litigation initiated in July 2022 in response to Fresenius' submission of an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval of a generic version of CINVANTI.&nbsp;
As a result of the decision, Heron will seek an order from the Court prohibiting Fresenius from launching its generic CINVANTI until after the expiration of the patents in 2035. This decision is subject to appeal.

Legal

HRTX

Heron Therapeutics Says US District Court Ruled In Its Favor In Patent Litigation Against Fresenius Kabi With Respect To CINVANTI Injectable Emulsion

China responded swiftly on Tuesday to new U.S. restrictions on semiconductor technology exports by imposing tighter controls on critical minerals used in <a href="https://www.benzinga.com/topic/semiconductors">chip manufacturing</a>.
The move targets gallium, germanium, and antimony — essential materials for advanced electronics and defense applications, The Wall Street Journal <a href="https://www.wsj.com/world/asia/china-tightens-curbs-on-exports-of-materials-with-chip-making-applications-to-u-s-4348a02c?mod=latest_headlines">reports</a>.
What Happened: A day after the U.S. blacklisted 140 Chinese entities and restricted exports of memory chips vital to artificial intelligence, Beijing retaliated with export bans and reviews for U.S.-bound shipments of these minerals. The Chinese Ministry of Commerce justified the measures as necessary for national security.
China also cautioned its businesses against purchasing American chips due to reliability and safety concerns. 
The restricted minerals are critical to the U.S. economy and defense supply chains, with Beijing accounting for a significant portion of imports between 2019 and 2022. For instance, the U.S. relied on China for 80% of its antimony needs during this period, WSJ reports.
Also Read: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42299957/feds-kugler-sees-inflation-progress-but-warns-policy-is-not-on-a-preset-course">Fed&#8217;s Kugler Sees Inflation Progress But Warns: &#8216;Policy Is Not On A Preset Course&#8217;</a>
The new U.S. export controls, which <a href="https://www.benzinga.com/government/regulations/24/12/42265847/biden-targets-china-with-new-chip-restrictions-nvidia-slides">took effect Monday</a>, primarily target Chinese firms such as Naura Technology Group, Huawei-linked companies and equipment manufacturers. These measures also extend restrictions to non-U.S. chip suppliers reliant on American technologies, sparking concern among global players like Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).
Why It Matters: The clash underscores the fragility of global supply chains and the geopolitical stakes tied to semiconductor dominance. With China tightening its grip on critical materials, the U.S. faces mounting pressure to diversify its supply sources. 
Experts warn these developments could reshape the global semiconductor landscape as companies and governments navigate new trade barriers. U.S. firms such as Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Lam Research Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and KLA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) may feel the ripple effects alongside international players exempt from these restrictions, including Dutch firm ASM International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>).
ETFs such as the Invesco Semiconductors ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSI#NASDAQ">PSI</a>) and the SPDR S&amp;P Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XSD#NYSE">XSD</a>) could also feel the effects of these trade restrictions, given their exposure to impacted companies.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/12/42301885/south-korea-etfs-won-pare-losses-as-yoon-makes-u-turn-on-martial-law-declaration">South Korea ETFs, Won Pare Losses As Yoon Makes U-Turn On Martial Law Declaration</a></li>
</ul>
Photo by Fahroni via Shutterstock

Asia

Global

ASML

KLAC

LRCX

NVDA

PowerShares Exchange-Traded Fund Trust Dynamic Semiconductor Portfolio

China Retaliates Against US Chip Sanctions, Tightens Mineral Exports

This increases the current amount of shares available for repurchase to approximately eleven million.

Cabot Board Boosts Share Repurchase Authorization By 10M Shares

WIIM

NOTV

Inotiv shares are trading lower after the company reported a year-over-year decrease in Q4 financial results.

THTX

Theratechnologies Resumes Production Of EGRIFTA SV Following Shutdown Of Facility To Address FDA Inspection

Salesforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) reported third-quarter financial results after the market close on Tuesday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/24/12/b42301590/salesforce-announces-third-quarter-fiscal-2025-results">from the quarter</a>.
Q2 Earnings:&nbsp;Salesforce reported third-quarter revenue of $9.44 billion, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $9.35 billion. The enterprise cloud solutions company reported adjusted earnings of $2.41 per share, missing analyst estimates of $2.44 per share, according to<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">&nbsp;Benzinga Pro</a>.
Total revenue was up 8% on a year-over-year basis. Operating margin came in at 20%, and non-GAAP operating margin was 33.1%. Cash flow from operations was up 29% year-over-year and free cash flow was up 30% year-over-year to $1.78 billion. The company ended the quarter with remaining performance obligations of $26.4 billion, up 10% year-over-year.
&#8220;We delivered another quarter of exceptional financial performance across revenue, margin, cash flow and cRPO,&#8221; said Marc Benioff, chair and CEO of Salesforce.
&#8220;Agentforce, our complete AI system for enterprises built into the Salesforce Platform, is at the heart of a groundbreaking transformation. The rise of autonomous AI agents is revolutionizing global labor, reshaping how industries operate and scale.&#8221;
Don&#8217;t Miss: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42297318/american-exceptionalism-trade-gains-steam-as-dollar-sp-500-surge-in-lockstep-bank-of-america">&#8216;American Exceptionalism Trade&#8217; Gains Steam As Dollar, S&amp;P 500 Surge In Lockstep: Bank Of America</a>
Salesforce said it repurchased $1.2 billion worth of its stock in the quarter and returned $400 million to shareholders in the form of dividend payments. 
Guidance: Salesforce expects fourth-quarter revenue to be in the range of $9.9 billion to $10.1 billion. The company anticipates fourth-quarter adjusted earnings of $2.57 to $2.62 per share.&nbsp;
Salesforce sees full-year 2025 revenue of $37.8 billion to $38 billion. The company expects full-year adjusted earnings to be between $9.98 and $10.03 per share.
&#8220;With Agentforce, we&#8217;re not just witnessing the future — we&#8217;re leading it, unleashing a new era of digital labor for every business and every industry,&#8221; Benioff said.
Management will further discuss the quarter on a conference call with analysts and investors at 5 p.m. E.T.
CRM Price Action: <a href="https://www.benzinga.com/quote/CRM" target="_blank" rel="noreferrer noopener">Salesforce shares</a> were up 7.72% in after-hours, trading at $357 at publication Tuesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

Salesforce Q3 Earnings: Revenue Beat, EPS Miss, Free Cash Flow Up 30%, AI Driving 'Groundbreaking Transformation' And More

LUNR

Intuitive Machines shares are trading higher after the company announced a $65 million public offering of common stock alongside a $10 million private placement.

Multi-year collaboration aims to expand artificial intelligence (AI) adoption, foster innovation, and enhance industry-specific solutions for diverse business leaders.
 &nbsp;

AMZN

Genpact Enters Multi-year Strategic Collaboration Agreement With Amazon Web Services

<a href="https://www.globenewswire.com/Tracker?data=ihXjcEoWxhQAg0vsph5i2W0UcUBuBqIjhjCCJmE_LLeZu5DkxYjGvVtULhCy_oyrAi2UNg3Bmci7IMZHybtb2CXkXlxzvhwuMVcPLskmd8YxCbG_n-7P1GaO_3pEY5rR">Outlook Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom earlier this year for LYTENAVA&#x2122; (bevacizumab gamma), the first ophthalmic formulation of bevacizumab authorized for the treatment of wet age-related macular degeneration (wet AMD) in adults, today announced that Russell Trenary has stepped down as the Company's President and Chief Executive Officer (CEO), effective immediately. Lawrence Kenyon, Executive Vice President, Chief Financial Officer and member of the board of directors, has been appointed Interim CEO.

OTLK

Outlook Therapeutics Announces Executive Leadership Transition; Russell Trenary Has Stepped Down As The Co's President And CEO, Effective Immediately. Lawrence Kenyon, Executive Vice President, CFO, Has Been Appointed Interim CEO

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Macrogenics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mgnx-stock-quote/">MGNX</a>) stock is dropping on Wednesday as the biopharmaceutical company prepares to <a href="https://www.nasdaq.com/press-release/macrogenics-provides-vobramitamab-duocarmazine-update-2024-07-30">discontinue a clinical trial</a> of vobramitamab duocarmazine.



This is the company&rsquo;s candidate for metastatic castration-resistant prostate cancer (mCRPC). The company has decided to no longer move forward with its TAMARACK Phase 2 study for patients who could have received additional doses.



Macrogenics&nbsp;is making this decision due to the primary endpoint of its study already being met. This suggestion came from the Independent Data Monitoring Committee (IDMC) of the clinical trial. It will present this data in a poster presentation in September.



Scott Koenig, M.D., Ph.D., president and CEO of&nbsp;MacroGenics, said the following about the news.




&ldquo;Patient safety is our top priority, and having reached the study&rsquo;s primary endpoint, we decided to discontinue additional dosing for the remaining TAMARACK participants who had not yet completed treatment. We expect to have the data necessary to determine next steps for the vobra duo program later this year and will provide further updates on an investor call following our ESMO presentation.&rdquo;




<h2>How This Affects MGNX Stock</h2>



Investors aren&rsquo;t reacting well to this news with shares of MGNX stock falling 28.2% as of Wednesday morning. The stock was also down 48.3% year-to-date when markets closed on Tuesday.



Investors who are seeking out even more of the most recent stock market stories today are in the right place!



We have all of the hottest stock market happenings that traders need to read about on Wednesday! That includes everything happening with shares of FibroGen&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/fgen-stock-quote/">FGEN</a>) stock, Nuzee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) stock and Primech&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/pmec-stock-quote/">PMEC</a>) stock this morning. You can catch up on all of these matters by checking out the links below!



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-fibrogen-fgen-stock-down-44-today/">Why Is FibroGen (FGEN) Stock Down 44% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-nuzee-nuze-stock-up-64-today/">Why Is Nuzee (NUZE) Stock Up 64% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-primech-pmec-stock-up-60-today/">Why Is Primech (PMEC) Stock Up 60% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-macrogenics-mgnx-stock-down-28-today/">Why is Macrogenics (MGNX) Stock Down 28% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why is Macrogenics (MGNX) Stock Down 28% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
FibroGen&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/fgen-stock-quote/">FGEN</a>) stock is falling hard on Wednesday after the biopharmaceutical company <a href="https://www.nasdaq.com/press-release/fibrogen-announces-topline-results-two-late-stage-pamrevlumab-pancreatic-cancer">reported results from failed clinical trials</a>.



The first failed clinical trial covers the treatment of metastatic pancreatic cancer with pamrevlumab. FibroGen&nbsp;said that this didn&rsquo;t meet its primary endpoint of overall survival. This was determined based on the protocol pre-specified Bayesian statistical analysis.



The second failed study covered the use of pamrevlumab&nbsp;combined with gemcitabine + nab-paclitaxel to treat unresectable pancreatic cancer. Yet again, the clinical trial failed to reach its primary endpoint of overall survival.



These are major blows to FibroGen&nbsp;as these weren&rsquo;t early clinical trials. The metastatic pancreatic cancer trial was in the Phase 2/3 range while the unresectable pancreatic cancer one was a Phase 3 study.



FibroGen&nbsp;CEO Thane Wettig said the following about the clinical trial results.




&ldquo;We are deeply disappointed that the pamrevlumab arm in the Precision Promise trial and the LAPIS trial did not meet the primary endpoint of overall survival. We were hopeful that pamrevlumab could bring meaningful innovation to pancreatic cancer patients in desperate need of new therapies.&rdquo;




<h2>What&rsquo;s Next for FGEN Stock</h2>



Considering the results of these clinical trials, FibroGen&nbsp;is immediately going to go into cost-saving mode. That includes the termination of the pamrevlumab program. This will reduce its total headcount by 75%.



FGEN stock is down 44.4% as of Wednesday morning.



Investors will want to stick around for more of the most recent stock market news!



We have all of the latest market happenings worth reading about today! A few examples include what&rsquo;s going on with shares of Nuzee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) and Primech&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/pmec-stock-quote/">PMEC</a>) stock, as well as the biggest pre-market stock movers this morning. All of this info is ready to go at the links below!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-nuzee-nuze-stock-up-64-today/">Why Is Nuzee (NUZE) Stock Up 64% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-primech-pmec-stock-up-60-today/">Why Is Primech (PMEC) Stock Up 60% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-31st/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Wednesday</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-fibrogen-fgen-stock-down-44-today/">Why Is FibroGen (FGEN) Stock Down 44% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is FibroGen (FGEN) Stock Down 44% Today?

Primech Holdings Ltd. (PMEC) has released an update. At Primech Holdings Ltd.'s 2024 Annual Meeting, shareholders overwhelmingly approved the Direc...

Primech Holdings Shareholders Approve Key Resolutions

Primech AI, a subsidiary of Primech Holdings (PMEC), announces the launch of Hytron, an AI-powered automated toilet cleaning robot, now operational...

Primech AI launches AI-powered automated toilet cleaning robot

Primech and its subsidiary, Primech AI, announce new strategic partnerships with Unity Group Holdings International Limited, a provider of energy s...

Primech Holdings, Primtech AI enter strategic partnerships with Unity Group

Primech AI, a subsidiary of Primech Holdings (PMEC), unveiled its strategic expansion plans for HYTRON, its AI-powered public toilet cleaning robot...

Primech Holdings subsidiary unveils future plans

Primech Holdings (PMEC) announced that it received a letter from Nasdaq, notifying the company that it is eligible for an additional 180 calendar d...

Primech Holdings receives noncompliance notification from Nasdaq

Primech receives Nasdaq minimum bid price requirement extension

Primech Holdings Ltd. (PMEC) has released an update. Primech Holdings Ltd. has been granted an additional 180-day extension by Nasdaq to meet the m...

Primech Holdings Granted Nasdaq Extension to Meet Bid Price

10:38 EST Primech Holdings (PMEC) files $50M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving br...

Primech Holdings files $50M mixed securities shelf

Press Releases

Primech Holdings Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Primech Holdings Launches Primech Ai, the Creator of a Fully Autonomous, Ai-Powered Toilet-Cleaning Robot

Primech Holdings Reports 5.1% Increase in Revenue, $144.4 Million in Future Contracted Revenues Guidance

Primech Holdings Subsidiary Nominated as a Finalist for the Singapore Apex Corporate Sustainability Awards

Primech Secures Major New Contracts, Paving the Way for Future Growth

Primech AI, a Subsidiary of Primech Holdings, Launches AI-Powered Automated Toilet Cleaning Robot, Hytron

Primech Holdings and Primech AI Forge Strategic Partnerships with Unity Group for Advanced Energy and Robotics Solutions

Primech AI, a Subsidiary of Primech Holdings, Unveils Ambitious Future Plans for its Innovative Toilet Cleaning Robot, HYTRON

Primech Holdings Subsidiary Primech A&P Earns Leading Industry Awards for Excellence in Cleanliness and Hygiene

Primech Holdings Receives NASDAQ Minimum Bid Price Requirement Extension

ABM Indus

Ambipar Emergency Response Class A Ordinary Shares

Ambipar Emergency

Aris Water Solutions, Inc. Class A Common Stock

Aris Water Solutions

Mobile Infrastructure Corporation Common Stock

Mobile Infrastructure

BrightView Hldgs

CDT Environmental Technology Investment Holdings Limited - ordinary shares

CDT Environmental

CECO Environmental

Clean Harbors

Casella Waste Systems, Inc. - Class A Common Stock

Casella Waste Sys

ESGL Holdings Limited - Class A Ordinary Shares

ESGL Holdings

Fuel Tech

Li-Cycle Holdings

LanzaTech Global

Montrose Environmental Group, Inc. Common Stock

Montrose Environmental Gr

Enviri

Perma-Fix Environmental Services, Inc. - Common Stock

Perma-Fix Envirn Servs

Quest Resource Holding Corporation - Common Stock

Quest Resource Holding

Rollins

Republic Servs

Rentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares)

Rentokil Initial

Team

Tetra Tech

Veralto

Waste Management

YY Group Holding Limited - Class A Ordinary Shares

YY Group Holding

アドバンスト マイクロ デバイセズ社 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) の株は、予想を上回る<a href="https://www.benzinga.com/news/earnings/24/07/40060832/amd-skyrockets-over-9-lifting-along-with-ai-rival-nvidia-whats-going-on">第2四半期決算</a>を受けて本日のプレマーケット取引で急騰している。
AMDは1株あたり69セントの四半期決算を報告し、これはアナリストの予想一致値である1株あたり68セントを上回った。また同社は、1株あたり5.8350億ドルの四半期売上を報告し、これはアナリストの予想一致値である1株あたり5.7240億ドルを上回った。これは<a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>のデータによるものだ。
AMDの株はプレマーケット取引で9.1％上昇し、151.01ドルになった。
以下は、プレマーケットで動いた他の銘柄の一部である。
<h3 class="wp-block-heading">上昇銘柄</h3>
<ul>
<li>Primech Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMEC#NASDAQ">PMEC</a>) の株は、火曜日に5％以上上昇した後プレマーケット取引で114.8％上昇し、1.13ドルになった。</li>
<li>Heramba Electric plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) の株は、火曜日に約49％下落した後、本日のプレマーケット取引で92.8％上昇し、8.29ドルになった。</li>
<li>NuZee, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) の株は、火曜日に約3％上昇した後、本日のプレマーケット取引で79.4％上昇し、6.64ドルになった。</li>
<li>Telesis Bio, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) の株は、プレマーケット取引で39.8％上昇し、5.52ドルとなった。</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) の株は、同社がナスダックの規制順守を回復した後、前日の取引で33.1％上昇したプレマーケット取引で0.4205ドルになった。</li>
<li>Powell Industries, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) の株は、3四半期の決算が予想を上回った後、プレマーケット取引で25.3％上昇し、167.02ドルになった。</li>
<li>BIMI Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) の株は、火曜日に約66％下落した後、プレマーケット取引で22.8％上昇し、0.48ドルになった。</li>
<li>DallasNews Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DALN#NASDAQ">DALN</a>) の株は、同社が第2四半期の財務決算で前年同期比で増収を報告した後、プレマーケット取引で19.1％上昇し、3.91ドルになった。</li>
<li>Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) の株は、同社がコマンチピーク原子力発電所の運営期間を2053年まで延長する許可を米原子力規制委員会から取得した後、プレマーケット取引で12.1％上昇し、77.35ドルになった。</li>
</ul>
<h3 class="wp-block-heading">下落銘柄</h3>
<ul>
<li>FibroGen, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) の株は、プレマーケット取引で40.2％下落し、0.6159ドルになった。同社は、膵臓がん患者におけるパムレブルマブの有効性と安全性を評価する2つの後期試験からの最上位結果を発表し、および転移性膵臓がん患者におけるパンブロキシマブの臨床データを報告した。</li>
<li>MacroGenics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) の株は、2024年の欧州医療腫瘍学会議での2相試験のプレゼンテーションを発表した後、プレマーケット取引で24.0％下落し、3.99ドルになった。</li>
<li>Jet.AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) の株は、ワラントに関する交換オファーと同意勧誘の結果を発表した後、プレマーケット取引で21.5％下落し、0.2631ドルになった。</li>
<li>Velo3D, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLD#NYSE">VLD</a>) の株は、火曜日に4％下落した後、プレマーケット取引で20.6％下落し、2.20ドルになった。</li>
<li>Penumbra, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) の株は、同社が第2四半期の決算を発表し、自社の2024会計年度の売上高予測の下方修正を行った後、プレマーケット取引で20.3％下落し、137.93ドルになった。</li>
<li>Groupon, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) の株は、第2四半期の一株当たり利益が予想を下回ったことを受け、プレマーケット取引で18.6％下落し、12.75ドルになった。</li>
<li>Definitive Healthcare Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) の株は、NeedhamのアナリストRyan MacDonald氏が同社の投資判断を「ホールド」に継続したことにより、プレマーケット取引で17.6％下落し、4.71ドルになった。</li>
<li>O-I Glass, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OI#NYSE">OI</a>) の株は、プレマーケット取引で15.5％下落し、9.80ドルになった。同社は2024年の業績見通しを下方修正した。</li>
<li>Lemonade, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) の株は、四半期決算を発表した後、プレマーケット取引で14.6％下落し、19.33ドルになった。</li>
<li>Tivic Health Systems, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) の株は、火曜日に約18％下落した後、プレマーケット取引で12.4％下落し、0.5056ドルになった。</li>
</ul>

Comments

Primech Holdings

ニュース

最新ニュース Primech Holdings (NASDAQ:PMEC) 株価情報

水曜日, 7 31, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル